153 related articles for article (PubMed ID: 38552851)
1. Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.
Yang L; Guttman L; Dawson VL; Dawson TM
Biochem Pharmacol; 2024 Mar; ():116174. PubMed ID: 38552851
[TBL] [Abstract][Full Text] [Related]
2. Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases.
Park H; Kam TI; Dawson TM; Dawson VL
Int Rev Cell Mol Biol; 2020; 353():1-29. PubMed ID: 32381174
[TBL] [Abstract][Full Text] [Related]
3. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
Liu L; Li J; Ke Y; Zeng X; Gao J; Ba X; Wang R
Cell Mol Life Sci; 2022 Jan; 79(1):60. PubMed ID: 35000037
[TBL] [Abstract][Full Text] [Related]
4. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
Xu X; Sun B; Zhao C
Neurobiol Dis; 2023 Oct; 187():106314. PubMed ID: 37783233
[TBL] [Abstract][Full Text] [Related]
5. Parthanatos in the pathogenesis of nervous system diseases.
Wang X; Ge P
Neuroscience; 2020 Nov; 449():241-250. PubMed ID: 33039521
[TBL] [Abstract][Full Text] [Related]
6. Blocking the Self-Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition.
Patel J; Dawson VL; Dawson TM
Mov Disord; 2024 Apr; 39(4):644-650. PubMed ID: 38396375
[TBL] [Abstract][Full Text] [Related]
7. Ceramide induces macrophage migration inhibitory factor -mediated parthanatos in mouse neurons by increasing ROS levels.
Fan C; Tian Y; Zhang Y; Teng J; Zhao X
Neurosci Lett; 2022 Sep; 788():136862. PubMed ID: 36075319
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches.
Zhang J; Hu X; Geng Y; Xiang L; Wu Y; Li Y; Yang L; Zhou K
J Adv Res; 2024 May; ():. PubMed ID: 38704090
[TBL] [Abstract][Full Text] [Related]
9. Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.
Thapa K; Khan H; Sharma U; Grewal AK; Singh TG
Life Sci; 2021 Feb; 267():118975. PubMed ID: 33387580
[TBL] [Abstract][Full Text] [Related]
10. Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension.
Lv ZC; Li F; Wang L; Zhao QH; Gang GS; Wu Y; Miao YQ; Yuan P
Am J Mens Health; 2021; 15(3):15579883211029458. PubMed ID: 34190625
[TBL] [Abstract][Full Text] [Related]
11. mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors.
Pan YR; Song JY; Fan B; Wang Y; Che L; Zhang SM; Chang YX; He C; Li GY
Cell Commun Signal; 2020 Feb; 18(1):27. PubMed ID: 32066462
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of PARP-1 and PARthanatos in ischemic stroke.
Liu S; Luo W; Wang Y
J Neurochem; 2022 Jan; 160(1):74-87. PubMed ID: 34241907
[TBL] [Abstract][Full Text] [Related]
13. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.
Fatokun AA; Dawson VL; Dawson TM
Br J Pharmacol; 2014 Apr; 171(8):2000-16. PubMed ID: 24684389
[TBL] [Abstract][Full Text] [Related]
14. PJ34 Protects Photoreceptors from Cell Death by Inhibiting PARP-1 Induced Parthanatos after Experimental Retinal Detachment.
Dong K; Yan Y; Lu L; Wang Y; Li J; Zhang M; Ding J
Curr Eye Res; 2021 Jan; 46(1):115-121. PubMed ID: 32478624
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
Wang Y; Kim NS; Haince JF; Kang HC; David KK; Andrabi SA; Poirier GG; Dawson VL; Dawson TM
Sci Signal; 2011 Apr; 4(167):ra20. PubMed ID: 21467298
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.
Wang Y; Dawson VL; Dawson TM
Exp Neurol; 2009 Aug; 218(2):193-202. PubMed ID: 19332058
[TBL] [Abstract][Full Text] [Related]
17. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53.
So KY; Oh SH
Biochem Biophys Res Commun; 2023 May; 656():78-85. PubMed ID: 36958258
[TBL] [Abstract][Full Text] [Related]
18. Parthanatos as a Cell Death Pathway Underlying Retinal Disease.
Greenwald SH; Pierce EA
Adv Exp Med Biol; 2019; 1185():323-327. PubMed ID: 31884632
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Inhibitors of Macrophage Migration Inhibitory Factor (MIF) Interfere with Apoptosis-Inducing Factor (AIF) Co-Localization to Prevent Parthanatos.
Chen D; Osipyan A; Adriana J; Kader M; Gureev M; Knol CWJ; Sigmund MC; Xiao Z; van der Wouden PE; Cool RH; Poelarends GJ; Dekker FJ
J Med Chem; 2023 Jul; 66(13):8767-8781. PubMed ID: 37352470
[TBL] [Abstract][Full Text] [Related]
20. Targeting Parthanatos in Ischemic Stroke.
Koehler RC; Dawson VL; Dawson TM
Front Neurol; 2021; 12():662034. PubMed ID: 34025565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
